Posts

Showing posts with the label Hormone Replacement Therapy Market

Hormone Replacement Therapy Market 2030: Key Factors Influencing Market Dynamics

Image
Market Size & Trends The global  hormone replacement therapy market size was valued at USD 21.28 billion in 2022 and is expected to grow at a compounded annual growth rate (CAGR) of 6.6% from 2023 to 2030. The hormone replacement therapy (HRT) market is witnessing growth due to factors such as the rising incidence of target diseases and the availability of long-acting hGH products. According to American Thyroid Association, around 12.0% of the U.S. population is estimated to suffer from thyroid during their lifetime. It also reported that approximately 20.0 million U.S. citizens have some form of thyroid disease. Several studies showed that people who are on hormone replacement therapy are likely to have a low risk of COVID-19 infection and mortality rate. A study led by the Oxford-Royal College of General Practitioners Research and Surveillance Centre studied 1.8 million medical records of women from 465 general practitioners and found 5,451 COVID cases linke...

Hormone Replacement Therapy Market 2030: The Impact of COVID-19 on Demand

Image
Hormone Replacement Therapy Market Growth & Trends The global  hormone replacement therapy market  size is expected to reach USD 35.79 billion by 2030, according to a new study by Grand View Research Inc. The market is expected to expand at a CAGR of 6.6% from 2023 to 2030. The growth in the hormone replacement therapy market is largely attributable to the rising prevalence of hormonal disorders coupled with technological advancements in drug delivery systems. According to the National Organization of Rare Diseases, there are around 70,000 people with hypoparathyroidism in the U.S. Technological advancements to minimize the side effects and enhance drug bioavailability are expected to boost the market growth. Due to better bioavailability, the treatment frequency increases. Products such as NGENLA, which is used to treat growth hormone deficiency, require a once-a-week dosage, which ensures better patient compliance. Furthermore, improvement in the route of administ...